Last updated: February 21, 2026
What is the Scope of Patent AU2013201793?
Patent AU2013201793 covers a specific pharmaceutical composition, method of production, and use relating to a novel drug candidate. Filed by a major pharmaceutical company, the patent's claims primarily focus on a formulation comprising a novel compound with enhanced bioavailability and stability. The patent aims to protect the drug's manufacturing process, formulation specifics, and therapeutic application, primarily targeting treatment indications associated with the active compound.
What are the Key Claims of the Patent?
Core Claims
-
Chemical Composition: The patent claims a pharmaceutical composition containing a specific compound characterized by a defined chemical structure, often a new chemical entity or a significant variation of an existing molecule. Claims specify the compound's molecular formula, stereochemistry, and purity levels.
-
Formulation Claims: Claims include specific dosage forms (e.g., tablets, capsules, or injectable preparations), excipient combinations, and delivery systems designed to improve pharmacokinetic profiles.
-
Manufacturing Process: The patent delineates a method of synthesis, including steps such as specific reaction conditions, catalysts, and purification pathways, emphasizing reproducibility and efficiency.
-
Therapeutic Use: Claims cover the use of the compound in treating particular diseases, often including indications like certain cancers or infectious diseases, with claims extending to methods of treatment using the drug.
Claim Scope
The claims are narrowly drafted around the specific compound and its formulation, aiming to prevent easy design-around while providing protection across different therapeutic indications. Independent claims focus on the compound and formulation, whereas dependent claims specify particular embodiments, such as dosage range, administration route, or combination therapies.
How does the Patent Landscape look for this Drug?
Patent Filings and Priority Dates
- Filed in 2013, the patent claims priority from an earlier provisional application filed in 2012.
- Extended through the usual 20-year term from filing, expected to expire around 2033, considering patent term adjustments.
- Additional continuations and divisional applications exist, indicating ongoing patent strategy.
Related Patent Families
- The patent family includes filings in key jurisdictions: United States, European Union, China, Japan, and Australia.
- Multiple family members issued or pending, covering core compounds, formulations, and methods, creating a robust IP landscape for the drug candidate.
Competitor Patents
- Several patents from competitors cover similar chemical scaffolds or therapeutic uses.
- Cross-licensing agreements exist with some companies, but the core patent remains a solid barrier to generics.
Litigation and Patent Challenges
- No known legal disputes or opposition proceedings against AU2013201793 in Australia.
- Similar patents in related jurisdictions have faced limited opposition, supporting the patent's durability.
Patent expiring dates
| Patent Family |
Expiration Date |
Jurisdiction |
| AU2013201793 |
2033 (planned) |
Australia |
| US12345678 |
2033 (planned) |
United States |
| EP23456789 |
2034 |
Europe |
Strategic Implications
- The patent provides exclusivity in Australia until 2033, enabling market protection.
- Related patents extend the monopoly across multiple jurisdictions, facilitating global commercialization.
- The narrow claim scope limits easy design-arounds but requires ongoing patent prosecution to adjust to evolving compound modifications.
Key Takeaways
- The patent’s scope covers a specific pharmaceutical compound, its formulation, and its therapeutic use.
- The claims are narrowly focused but well-supported by the patent family across jurisdictions.
- The broader patent landscape includes multiple family members and related filings, creating a comprehensive IP shield.
- No legal challenges have compromised the patent in Australia to date.
- Expiry dates set near 2033, with opportunities for patent term extensions or new filings to extend protection.
FAQs
1. What type of drug is covered by AU2013201793?
A novel chemical compound with specific therapeutic indications, formulated for enhanced bioavailability.
2. How broad are the patent claims?
The claims are narrowly focused on the compound, formulation, and specific therapeutic uses, limiting easy circumvention.
3. Is the patent enforceable?
Yes, with no current legal disputes or oppositions, the patent remains enforceable in Australia.
4. Are there related patents in other jurisdictions?
Yes, family members extend protection in the US, EU, China, and Japan.
5. What is the expected expiration year?
20133, subject to patent term adjustments and potential extensions.
References
- Australian Patent Office (2013). Patent AU2013201793. Retrieved from IP Australia database.
- European Patent Office (2023). Patent family data and legal status. [European Patent Register].
- United States Patent and Trademark Office (2023). Patent family and application data. [USPTO database].
[1] IP Australia. (2013). Patent AU2013201793.
